Back to search results

Study of an AI Chatbot for Caregivers

This study is looking at how practical and helpful an artificial intelligence (AI) chatbot app, called an LLM-based Chatbot, is for family caregivers. You might be able to join if you are an adult caregiver (18 years or older) for someone with a traumatic brain injury (TBI), dementia, or Huntington disease (HD), and you have an Apple device and internet access. The study will test the LLM-based Chatbot over 8 weeks, with 4 weeks focused on physical health and 4 weeks on mental health. The main goal is to see how feasible and acceptable the chatbot is to use, as measured by a questionnaire at the end of the 8 weeks. Up to 60 caregivers are planned to participate.

Study design
This is an interventional study involving up to 60 participants. It is not specified if it is randomized or blinded.
What's involved
You would download and use the AI chatbot app (Earkick) for 8 weeks, focusing on different health topics. You will complete surveys at the midpoint and end of the study, and participate in a semi-structured interview.
Compensation
Not stated in the trial record.
Follow-up
Participants will be assessed at 8 weeks (post intervention).

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07280650

Feasibility and Acceptability of an LLM-based Chatbot for Family Caregivers: Evaluation Study

Not Yet Recruiting
NAAges 18+InterventionalHealth services
University of Michigan
~60 participants
Updated 2026-04-20 on ClinicalTrials.gov
What's tested:LLM-based Chatbot

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility and Acceptability as measured by the Feasibility Questionnaire
Measured over 8 weeks (post intervention)

Conditions

Caregivers

Explore related trials

DementiaHuntington's DiseaseTraumatic Encephalopathy

NCT07280650

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Michigan

    Ann Arbor, Michiganstudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Noelle Carlozzi, PhD · PRINCIPAL_INVESTIGATOR · University of Michigan

Who to contact

Christopher Graves
[email protected]
734-764-7004
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age 18 years or older
Able to independently provide informed consent
Able to read, speak, and understand English
Have an Apple (iOS) smartphone, tablet, or laptop, have access to the internet and text messages, and be willing to use these resources for the study, including downloading and using the AI chatbot app (Earkick)
Be caring for and adult with a medically documented diagnosis of TBI, dementia or Huntington disease (HD)
Provide emotional, physical, and/or financial support/assistance to the individual with the TBI, dementia, or HD, indicating a response per protocol
Indicate high levels of caregiver burden, confirmed using the 12-item Zarit Burden questionnaire (scores must be ≥20)
Willing to complete all study assessments for the duration of their study participation
Age 18 years or older
Have a medically documented diagnosis of TBI, dementia or Huntington disease as noted per protocol
Professional, paid caregivers
Anyone at the discretion of the Principal investigator (PI) that would be a preclusion of safe or meaningful participation
Lives in a care facility (assisted living, nursing home) or is bedbound

What this trial measures

  • Feasibility and Acceptability as measured by the Feasibility Questionnaire8 weeks (post intervention)

    Feasibility Questionnaire (items are scaled from 1 to 5 to indicate level of agreement, where "1" indicates "strong disagreement" and "5" indicates "strong agreement"). Feasibility and Acceptability as measured by ≥80% of participants indicating that care partners either "Agree" or "Strongly Agree" that the different study elements are feasible and acceptable.